Study on How Fiasp® Can Influence Blood Sugar Levels of type1 Diabetic Patients in Their Daily Lives, With the Help of the Freestyle Libre® Device
Clinical trial NCT03450863 · COMPLETED
Trial details
- NCT number
- NCT03450863
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-03-22
- Primary completion
- 2019-09-04
- Enrollment
- 320
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.